Amgen, a leading biopharmaceutical company, has recently transitioned its enterprise AI tool from Microsoft's Copilot to OpenAI's ChatGPT. This strategic shift underscores the intensifying competition between Microsoft and OpenAI in the enterprise AI market.
Amgen's decision to adopt ChatGPT was...
ai adoption
ai competition
ai ecosystem
ai in research
ai innovation
ai integration
ai market trends
aiplatformconnectionsai technology advancement
ai tools in business
ai usability
ai user experience
biopharmaceutical ai
chatgpt
corporate ai strategy
enterprise ai
enterprise software
microsoft copilot
openai
